封面
市場調查報告書
商品編碼
1887629

全球醫藥玻璃包裝市場

Pharmaceutical Glass Packaging

出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 377 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

全球醫藥玻璃包裝市場預計2030年將達到344億美元

2024年全球醫藥玻璃包裝市場規模估計為222億美元,預計到2030年將達到344億美元,在分析期間(2024-2030年)內複合年成長率(CAGR)為7.6%。本報告分析的細分市場之一-藥瓶,預計複合年成長率為5.8%,到分析期末將達到105億美元。管瓶細分市場預計在分析期間內複合年成長率為8.2%。

美國市場規模估計為65億美元,而中國市場預計將以8.7%的複合年成長率成長。

預計到2024年,美國醫藥玻璃包裝市場規模將達65億美元。作為世界第二大經濟體,中國市場預計到2030年將達到54億美元,在2024年至2030年的分析期間內,年複合成長率(CAGR)將達到8.7%。其他值得關注的區域市場包括日本和加拿大,預計在分析期內,這兩個市場的年複合成長率將分別達到6.5%和7.1%。在歐洲,德國的年複合成長率預計將達到約7.0%。

全球醫藥玻璃包裝市場-主要市場趨勢與促進因素概述

為什麼玻璃是藥品包裝的黃金標準?

玻璃包裝因其卓越的阻隔性能、化學穩定性和透明性,長期以來在製藥業備受推崇,成為確保藥品安全性、純度和有效性的首選材料。製藥玻璃包裝主要包括瓶子、管瓶、安瓿和注射器,用於儲存各種藥物,從簡單的維生素補充劑到複雜的生物製藥和疫苗。玻璃的惰性確保其不會與內容物發生反應,這對於易受其他物質污染或改變性質的敏感藥物至關重要。此外,玻璃能夠承受高溫滅菌過程,使其成為維持許多製藥應用所需無菌環境的關鍵材料。

玻璃包裝技術的創新如何惠及製藥業?

醫藥玻璃包裝領域的持續創新致力於提升玻璃容器的安全性和功能性,同時最大限度地降低破損和污染等風險。其中一項關鍵進展是硼矽酸玻璃的研發,這種玻璃具有極高的抗熱衝擊和抗化學浸出性能,為關鍵藥品提供了更安全的容器。此外,各公司也正在投資表面處理和塗層技術,以提高管瓶的耐用性和性能,並防止分層和顆粒產生等問題。這些技術進步不僅延長了藥品的保存期限,還透過減少材料廢棄物和提高生產效率,助力產業轉型為更永續的實踐。

哪些趨勢將塑造醫藥玻璃包裝的未來?

在塑造醫藥玻璃包裝未來發展的幾個主流趨勢中,生物技術的興起和生物製藥(包括疫苗和生物製藥)的快速發展尤其關鍵。這些產品需要嚴格的包裝規格以維持其分子結構的完整性,而這種轉變正推動著市場對高品質、耐用且可客製化的玻璃包裝解決方案的需求。此外,全球監管機構對醫藥包裝日益嚴格的監管壓力,旨在確保病患安全和產品質量,這迫使製藥公司和玻璃包裝製造商遵守更高的標準。同時,包裝的永續性也日益受到重視,製藥業正尋求透過更多可回收材料和更有效率的生產流程來減少其對環境的影響。

哪些因素推動了醫藥玻璃包裝市場的成長?

醫藥玻璃包裝市場的成長受多種因素驅動,包括生物製藥需求的不斷成長,以及對複雜、敏感藥物配方(需要高品質包裝解決方案)的需求。玻璃製造和加工技術的進步使製造商能夠生產出更堅固、更安全的產品,滿足製藥業的嚴格要求。此外,監管機構對更安全可靠的包裝解決方案的要求也促使製藥業轉向玻璃等可靠材料。消費行為也是關鍵促進因素。消費者對藥品安全性和品質的日益重視,使其更傾向於選擇玻璃包裝的藥品,因為玻璃具有非反應性。全球醫療保健成本的上升以及新興市場製藥行業的擴張進一步擴大了對醫藥玻璃包裝的需求,鞏固了其在全球醫療產品供應中的關鍵作用。

部分:

產品類型(瓶裝、管瓶、安瓿瓶裝、藥筒及注射器),藥品類型(非專利、品牌名稱、生物製藥)

受訪公司範例

  • Becton, Dickinson and Company
  • Corning, Inc.
  • Gerresheimer AG
  • Ardagh Group SA
  • Agrado SA
  • Beatson Clark PLC
  • Hindusthan National Glass &Industries Ltd.
  • Bormioli Pharma Spa
  • DWK Life Sciences LLC
  • Haldyn Glass Ltd.
  • ESSCO Glass
  • Dobbies Garden Centres Limited
  • Can Do Company Limited
  • As One Corporation
  • Dunelm(Soft Furnishings)Limited

人工智慧整合

我們正在利用檢驗的專家內容和人工智慧工具,改變您分析市場和競爭情報的方式。

Market Glass, Inc. 並沒有採用查詢LLM 或產業專用的SLM 的典型方法,而是建立了一個由世界各地領域專家精心策劃的內容庫,其中包括影片文字稿、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

在最新發布的報告中,Market Glass, Inc. 將關稅對地理市場的影響納入考量,並根據公司總部所在地、製造地以及進出口(成品和OEM產品)情況,預測企業競爭地位的變化。這種複雜多變的市場現實會從多個方面影響競爭對手,包括增加銷貨成本、降低盈利和重組供應鏈,同時也會影響微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 亞太其他地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP13956

Global Pharmaceutical Glass Packaging Market to Reach US$34.4 Billion by 2030

The global market for Pharmaceutical Glass Packaging estimated at US$22.2 Billion in the year 2024, is expected to reach US$34.4 Billion by 2030, growing at a CAGR of 7.6% over the analysis period 2024-2030. Bottles, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$10.5 Billion by the end of the analysis period. Growth in the Vials segment is estimated at 8.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$6.5 Billion While China is Forecast to Grow at 8.7% CAGR

The Pharmaceutical Glass Packaging market in the U.S. is estimated at US$6.5 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$5.4 Billion by the year 2030 trailing a CAGR of 8.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.5% and 7.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.0% CAGR.

Global Pharmaceutical Glass Packaging Market - Key Trends & Drivers Summarized

Why Is Glass the Gold Standard for Pharmaceutical Packaging?

Glass packaging has long been revered in the pharmaceutical industry for its exceptional barrier properties, chemical stability, and transparency, making it a preferred material for ensuring the safety, purity, and efficacy of pharmaceutical products. Pharmaceutical glass packaging primarily includes bottles, vials, ampoules, and syringes that are used to store everything from simple vitamins to complex biologics and vaccines. The inert nature of glass ensures that it does not react with the contents it holds, a critical requirement for sensitive medications that could be altered or contaminated by other materials. Additionally, glass's ability to withstand sterilization processes at high temperatures makes it indispensable for maintaining the sterile conditions required for many pharmaceutical applications.

How Are Innovations in Glass Packaging Benefiting the Pharmaceutical Industry?

The ongoing innovations in pharmaceutical glass packaging focus on enhancing the safety and functionality of glass containers while minimizing risks such as breakage and contamination. One of the key advancements has been the development of borosilicate glass, which is highly resistant to thermal shock and chemical leaching, thereby providing an even safer container for critical medications. Additionally, companies are investing in surface treatments and coating technologies that enhance the durability and performance of glass vials, preventing issues like delamination and particle generation. These technological advancements not only extend the shelf life of pharmaceutical products but also support the industry's shift towards more sustainable practices by reducing material waste and improving manufacturing efficiencies.

What Trends Are Shaping the Future of Pharmaceutical Glass Packaging?

Several prevailing trends are shaping the future of pharmaceutical glass packaging. The rise in biotechnology and the increasing development of biopharmaceuticals, including vaccines and biologics, which often require stringent packaging specifications to maintain molecular integrity, is a significant factor. This shift is driving demand for high-quality, durable, and customizable glass packaging solutions. Additionally, the global push towards stricter regulations on pharmaceutical packaging to ensure patient safety and product quality is prompting pharmaceutical companies and glass packaging manufacturers to adhere to higher standards. There is also a growing trend towards sustainability in packaging, with the pharmaceutical sector seeking ways to reduce its environmental footprint through more recyclable materials and efficient manufacturing processes.

What Factors Are Catalyzing the Growth of the Pharmaceutical Glass Packaging Market?

The growth in the pharmaceutical glass packaging market is driven by several factors, including the increasing demand for biologics and the need for complex and sensitive drug formulations that require high-quality packaging solutions. Technological advancements in glass production and treatment methods are enabling manufacturers to produce more robust and safer products, catering to the stringent requirements of the pharmaceutical industry. Moreover, regulatory requirements for safer and more secure packaging solutions are pushing the pharmaceutical sector towards more reliable materials like glass. Consumer behavior is also a significant driver; as the awareness of drug safety and quality increases, so does the preference for pharmaceutical products packaged in glass due to its non-reactive nature. The global increase in healthcare expenditures and the expansion of the pharmaceutical industry in emerging markets are further amplifying the demand for pharmaceutical glass packaging, ensuring its pivotal role in the delivery of healthcare products worldwide.

SCOPE OF STUDY:

The report analyzes the Pharmaceutical Glass Packaging market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Bottles, Vials, Ampoules, Cartridges & Syringes); Drug Type (Generic, Branded, Biologic)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 41 Featured) -

  • Becton, Dickinson and Company
  • Corning, Inc.
  • Gerresheimer AG
  • Ardagh Group SA
  • Agrado SA
  • Beatson Clark PLC
  • Hindusthan National Glass & Industries Ltd.
  • Bormioli Pharma S.p.a.
  • DWK Life Sciences LLC
  • Haldyn Glass Ltd.
  • ESSCO Glass
  • Dobbies Garden Centres Limited
  • Can Do Company Limited
  • As One Corporation
  • Dunelm (Soft Furnishings) Limited

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Glass Packaging: Sustainable, Green, and Pure Form of Packaging
    • An Introduction to Pharmaceutical Glass Packaging
    • Types of Glass Containers Used for Packaging in Pharmaceutical Industry
    • Pharmaceutical Glass Packaging Product Types
    • Key Advantages & Disadvantages of Glass Containers
    • Global Market Prospects & Outlook
    • Glass Bottles: The Largest Product Type
    • Generic Drugs Represent the Largest Segment
    • Developed Regions Lead the Pharmaceutical Glass Packaging Market
    • Growth of Pharmaceutical Manufacturing in Developing Economies Supports Market
    • Competition
    • Recent Market Activity
    • Pharmaceutical Glass Packaging - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Strong Rise in Pharmaceutical Sales to Drive Demand for Glass Packaging Solutions
    • Global Prescription Drug Sales (In US$ Billion) for the Years 2017, 2019, 2021, 2023 & 2025
    • Rapid Growth of Generic Drugs Augurs Well for Glass Packaging Market
    • Global Generic Drugs Market Size (in $ Billion) for the Years 2016, 2019, 2020 & 2025
    • Increasing Significance of Biologic Drugs Fuels Innovations in Packaging and Delivery Techniques
    • Global Biologic Drugs Market Size (in US$ Billion) for the Years 2019, 2022 & 2025
    • Aging Population, Increasing Burden of Chronic Disease and Consequent Rise in Demand for Injectables Drugs Augurs Well for Glass Packaging
    • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
    • World Diabetes and Population Statistics (2019, 2030 & 2045)
    • Contract Packaging Trend Augurs Well for the Pharma Glass Packaging Market
    • Ampoules Emerge as a Preferred Packaging Option for Pharma Companies
    • Parenteral Packaging Market Drives Demand for Glass Vials & Ampoules
    • Silica Bottles Facilitate Targeted Drug Delivery
    • Innovative Glass Packaging Solutions Help Improve Quality of Drugs
    • Innovations & Advancements Drive Market Growth
    • SCHOTT Offers syriQ BioPure(R) and SCHOTT TOPPAC(R) Syringes
    • Corning Creates Boron-Free Valor(R) Glass
    • Recyclability and Sustainability Increases Commodity Value of Glass, Paving Way for Use in Pharma Sector
    • Impending Phase-out of Plastic Brings to Light the Importance of Glass for Pharmaceutical Packaging Companies
    • Glass Flakes: A Key Concern for the Pharmaceutical Glass Packaging Manufacturers
    • Aluminosilicate Glass Emerges as a Solution to the Issue of Glass Flakes
    • Product Recall Incidents Likely to Hamper Market Stability
    • Alternative Materials Present A Threat to Glass Packaging in Pharmaceutical Industry
    • High Cost of Glass Packaging Containers: A Major Market Restraint
    • Cost Breakdown for Container Glass by Components
    • Emphasis on Product Integrity Drives Need for Anti-Counterfeit Pharmaceutical Packaging
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Pharmaceutical Glass Packaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 3: World 16-Year Perspective for Pharmaceutical Glass Packaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Bottles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Bottles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 6: World 16-Year Perspective for Bottles by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Vials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Vials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 9: World 16-Year Perspective for Vials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Ampoules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Ampoules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 12: World 16-Year Perspective for Ampoules by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Cartridges & Syringes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Cartridges & Syringes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 15: World 16-Year Perspective for Cartridges & Syringes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Generic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Generic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 18: World 16-Year Perspective for Generic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Branded by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Branded by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 21: World 16-Year Perspective for Branded by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Biologic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Biologic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 24: World 16-Year Perspective for Biologic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 25: World Pharmaceutical Glass Packaging Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Pharmaceutical Glass Packaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • Pharmaceutical Packaging Market in the US: An Overview
    • US Pharmaceutical Packaging Market by Material (in %) for 2023
    • TABLE 26: USA Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • JAPAN
    • Pharmaceutical Glass Packaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • CHINA
    • Pharmaceutical Glass Packaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • Market Overview
    • TABLE 44: China Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: China 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: China 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • EUROPE
    • Pharmaceutical Glass Packaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • Europe Pharmaceutical Packaging: A Prelude
    • Europe Pharmaceutical Packaging Materials Market by Application (in %) for 2023
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Pharmaceutical Glass Packaging by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Pharmaceutical Glass Packaging by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • FRANCE
    • Pharmaceutical Glass Packaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: France 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: France 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • GERMANY
    • Pharmaceutical Glass Packaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Pharmaceutical Glass Packaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Pharmaceutical Glass Packaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • Market Overview
    • Asia-Pacific to Witness Introduction of New Syringes and Ampoules
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Pharmaceutical Glass Packaging by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Pharmaceutical Glass Packaging by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Pharmaceutical Glass Packaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • INDIA
    • Pharmaceutical Glass Packaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • Changing Product Portfolio Composition Drives Spending on Packaging
    • TABLE 116: India Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 118: India 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 121: India 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Pharmaceutical Glass Packaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • Vials and Ampoules to Witness Robust Demand in Latin America
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Pharmaceutical Glass Packaging by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Pharmaceutical Glass Packaging by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Pharmaceutical Glass Packaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Pharmaceutical Glass Packaging by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Pharmaceutical Glass Packaging by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • AFRICA
    • Pharmaceutical Glass Packaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030

IV. COMPETITION